Scientists at Mount Sinai Discover a Key Mechanism for the Most Common Form of Alzheimer's Disease April 25, 2013 Research identifies potential therapeutic targets for Late Onset Alzheimer's Disease (LOAD) by revealing a network of genes involved in the inflammatory response.
MedPage Today - "Dementia Tab Set to Top $200 Billion" April 3, 2013
Global Post - "Dementia Costlier than Cancer, Heart Disease" April 3, 2013
Mount Sinai Leads Global Program Using Stem Cells to Accelerate Cures for Alzheimer's Disease March 27, 2013 Researchers collaborate with the New York Stem Cell Foundation using skin samples and brain imaging to identify causes and cures.
New Drug Is Safe and Effective in Reducing 'Off' Time in People with Parkinson's Disease March 21, 2013 New research in Parkinson's disease and Alzheimer's disease were presented at the American Academy of Neurology meeting this week.
NBC News – Today Show – Total Memory Makeover March 5, 2013
New York Times – "For Alzheimer’s, Detection Advances Outpace Treatment Options" November 15, 2012 A new brain scan technology, which went on the market in June, is spreading fast.
NPR - "Treatment For Alzheimer's Should Start Years Before Disease Sets In" October 17, 2012
New York Amsterdam News - "Mount Sinai Teams Up with 92nd Street Y in September to Offer a Month of Free Health Screenings" September 10, 2012
NBC Nightly News – Dr. Sam Gandy: "Detecting Alzheimer's" September 7, 2012 Scientists discovered the brain changes leading to Alzheimer's begin decades before any symptoms, which may mean people at risk could be identified long before they start to have any memory loss.
EurekAlert.com - "Rejected Drug May Protect Against Toxic Substance Common to Both Alzheimer’s and Parkinson’s Diseases" August 13, 2012 Latrepirdine, which failed in U.S. Clinical Trials of Alzheimer’s Disease, is showing new potential in an animal model.
Researchers Rediscover Potential of Rejected Alzheimer’s Drug to Arrest Progression of Disease in Mice August 8, 2012 Study Suggests that Latrepirdine, Which Previously Failed in Clinical Trials, May Be Successful if Tested on Patients with Earlier Stages of the Disease
Wall Street Daily - “Most Significant Finding in 20 Years” July 18, 2012
Reuters - "Alzheimer's Discovery Spurs New Hope For Future Prevention" July 17, 2012
New York Times - "Small Trial Hints Drug Can Slow Alzheimer’s" July 17, 2012
New York Times - "In Preventing Alzheimer's, Mutation May Aid Drug Quest" July 11, 2012
Mount Sinai Performs First Imaging Test to Detect Alzheimer's Disease in the Clinical Setting June 20, 2012 The new technique is expected to play a critical role in Alzheimer's disease diagnosis and in research leading to a cure.
CBS Evening News - Dr. Sam Gandy: "New Test Can Diagnose Alzheimer's, But Raises Questions" June 19, 2012
ABCNews.com - Dr. Sam Gandy: “Omega-3 Fatty Acids May Not Offer Touted Brain Benefits After All” June 13, 2012
Medical Xpress - Dr. Giulio Maria Pasinetti: “Biosynthetic Grape-Derived Compound Prevents Progression Of Alzheimer's Disease In Mice” May 3, 2012
Grape-Derived Compound Prevents Alzheimer's Disease Progression in Mice May 2, 2012 Mount Sinai researchers harnessed the beneficial effects of grape-seed extract on the brain and developed a biosynthetic compound that improves cognition in mice.
Researchers Gain Better Understanding of the Mechanism Behind Alzheimer's Disease Progression May 1, 2012 Mount Sinai scientists have determined how a pathological brain protein called tau contributes to the progression of Alzheimer's disease.
Ivanhoe - Dr. Giulio Maria Pasinetti: “Possible Alzheimer's Vaccine” April 27, 2012
Mount Sinai to Hold Focus on Safety Fair March 6, 2012 For National Patient Safety Awareness Week, Mount Sinai will hold a Safety Fair on Thursday, March 8th.
Decaffeinated Coffee Improves Brain Energy Metabolism in an Animal Study February 2, 2012 Mount Sinai researchers have found that decaffeinated coffee may reduce impaired brain energy metabolism associated with type 2 diabetes, a known risk factor for neurocognitive disorders.
HealthDay - Dr. Sam Gandy: “U.S. Wants to Buttress Alzheimer's Arsenal by 2025” January 18, 2012
StopAgingNow.com - Dr. Giulio Pasinetti: “Grape Seed Extract Fights Alzheimer’s” October 4, 2011
HealthDay - Dr. Mary Sano: “Certain 'Senior Moments' May Signal Mental Decline” September 15, 2011
HealthDay - Dr. Sam Gandy: “Moderate Drinking May Help Prevent Alzheimer's, Other Dementia” August 16, 2011
Nature Medicine - Dr. Sam Gandy: “Alzheimer’s Therapy: A BACE In The Hand?” August 4, 2011
Medscape - Dr. Mary Sano: “New Data on Long-Term Safety With Bapineuzumab in Alzheimer’s Disease” July 29, 2011
HealthDay - Dr. Sam Gandy: “Ex-NFL Players May Face Higher Brain Damage Risk: Study” July 18, 2011
Gene that Causes Type 2 Diabetes May Also Cause Alzheimer’s July 18, 2011 Researchers have found that a gene that causes diabetes kills nerve cells in the brain, possibly resulting in Alzheimer’s disease.
A Natural Chemical Found in Grape Seeds May Prevent Development or Progression of Alzheimer’s July 15, 2011 Mount Sinai researchers found that polyphenols, a natural extract found in grapes, may help prevent or treat Alzheimer’s disease.
MSNBC - Dr. Sam Gandy: “Scientist: Treat Alzheimer's 20 Years Before Symptoms” July 13, 2011
New Research Shows the Aging Brain Does Not Respond To Experience As Well as the Younger Brain May 24, 2011 Mount Sinai researchers have found reduced ability of the aging brain to learn and respond to experiences, a finding that sheds new light on the aging process.
Indications of Alzheimer’s Disease May Be Evident Decades Before First Signs of Cognitive Impairment March 28, 2011 Mount Sinai Researchers find a link between lower glucose utilization in the brain and Alzheimer’s disease.
Mount Sinai Launches Neuroimaging Study to Understand Brain Changes in Alzheimer’s Disease March 8, 2011 Funded by the NIH, the study will use imaging techniques and biomarkers to understand changes in the structure and function of the brain.
Researchers Find Star-Shaped Brain Cell That Support Neurons Also Aid in Formation of Long-Term Memories March 4, 2011 Lactate, which is energy fuel produced in a type of brain cell called an astrocyte, plays a critical role in long-term memory formation.
Mount Sinai Researchers Find That Little-Studied Gene May Boost Long-Term Memory and Enhance Cognition January 26, 2011 Treatment with a gene called IGF-II significantly improved long-term memory. When the gene was blocked, long-term memories could not form.
Gene Associated with Type 2 Diabetes Is Low in People with Alzheimer’s Disease October 12, 2010 A study in the journal Aging Cell shows that people with Alzheimer’s disease have a low level of the gene PGC-1, which regulates glucose.
Mount Sinai Researchers Identify Key Mechanism in Gene Linking Diabetes to Alzheimer’s September 28, 2010 Dr. Sam Gandy and his team have found that that a gene for a protein that may cause type 2 diabetes impacts the development of Alzheimer’s disease.
EmaxHealth: Gene Linked to Increased Risk of Alzheimer’s Disease September 24, 2010 Mount Sinai investigators share in discovery of gene that may improve Alzheimer’s treatment.
Mount Sinai Study Shows That Major Alzheimer’s Risk Gene Causes Alterations in Shapes of Brain Protein Deposits July 14, 2010 A team led by Dr. Sam Gandy is presenting new research at the Alzheimer's Association International Conference on Alzheimer's Disease
Antihypertensive Drugs May Protect against Alzheimer’s Disease and Promote Healthy Memory June 24, 2010 Researchers at Mount Sinai School of Medicine have found that a blood pressure drug may lessen the impact of Alzheimer’s disease and promote healthy memory.
